InvestorsHub Logo
Followers 139
Posts 23788
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 05/09/2024 10:08:20 AM

Thursday, May 09, 2024 10:08:20 AM

Post# of 470800

"...blarcamesine demonstrated a strong anti-amyloid effect, as indicated by a significant increase in the plasma Aß42/40 ratio, a validated biomarker of amyloid beta pathology. MRI scans revealed a notable reduction in brain volume loss across various brain regions, including the whole brain.

In terms of safety, the treatment-emergent adverse events primarily included transient and mostly mild to moderate dizziness, reported in a proportion of participants during the titration and maintenance phases of blarcamesine administration..."



https://www.sciencetimes.com/amp/articles/50071/20240508/anavex-life-sciences-alzheimers-treatment-brings-hope-to-millions.htm

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News